Exercise-induced 3-oxoLCA promotes antitumor immunity with CD8⁺ T-cell involvement in colorectal cancer
Exercise is associated with reduced colorectal cancer risk, but the circulating factors linking exercise to antitumor immunity remain unclear. Here we show that plasma collected within one hour after exercise suppresses colorectal tumor growth in mice. Metabolic profiling identifies 3-oxolithocholic acid, a bile acid metabolite that increases after acute exercise in mice and humans. Oral administration of this metabolite suppresses tumor growth and is associated with increased tumor infiltration by CD8 + T cells, which can kill cancer cells, and altered immune-response markers. Exploratory single-cell analysis reveals differences in gene activity related to immune function and metabolism in these cells. Depletion of CD8 + T cells attenuates, but does not eliminate, tumor suppression. These findings identify an exercise-responsive metabolite that promotes antitumor immunity in a mouse model of colorectal cancer and support a contribution from CD8 + T cells, while leaving additional mechanisms unresolved.
Authors
- Hui Shi (ORCID: https://orcid.org/0000-0002-3574-8807)
- Xinyue Bai (ORCID: https://orcid.org/0000-0003-1110-609X)
- Haoyu Pan (ORCID: https://orcid.org/0009-0007-9869-5814)
- Qiuyu Wang (ORCID: https://orcid.org/0000-0001-9533-0202)
- Yue Shi (ORCID: https://orcid.org/0000-0002-4528-8146)
- Mengsi Chen (ORCID: https://orcid.org/0009-0008-2989-8877)
- Die Wu
- Lunuo Hu (ORCID: https://orcid.org/0009-0003-9589-1861)
- Tiancheng Zhou
- Jianzhou Wu
- Xiaohan Wei
- Shiyan Gu
- Yuying Fan
- Fei Li
- Xinxin Shi
- Ying Chen
- Xingyi Wei
- Xufeng Wang
- Zehui He
- Zhixia Yang
- Changyu He
Institutions
- Shanghai Jiao Tong University (CN)
- Shanghai University of Sport (CN)
- Fudan University (CN)
- Ruijin Hospital (CN)
- Zhongshan Hospital (CN)
- Huashan Hospital (CN)
Publication Details
- Journal
- Communications Biology
- Published
- 2026-11-15
- DOI
- https://doi.org/10.1038/s42003-026-11369-4
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 0.00